AVEO PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
4

FORM 4

Filing date
12 Mar 2012
Reporting date
08 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Mar 2012
Reporting date
05 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Mar 2012
Reporting date
24 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
29 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Feb 2012
Reporting date
24 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Feb 2012
Reporting date
23 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
22 Feb 2012
Reporting date
21 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KUCHERLAPATI FORM 4

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

HA-NGOC FORM 4

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

SC 13G/A

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

SC 13G/A filing

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
14 Feb 2012
Reporting date
14 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

SCHEDULE 13G

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

AVEO13GAMEND2

Filing date
10 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

KUCHERLAPATI FORM 4/A

Filing date
09 Feb 2012
Reporting date
15 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

SC 13G

Filing date
09 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
06 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EZICKSON FORM 4

Filing date
02 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
02 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .